EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Synthesis, Antimicrobial, and Anticancer Activities of Novel Nitrofuran Derivatives

Malik Suliman Mohamed, Khaled M. Elamin, Rawaf Alenazy, Eyman Mohamed Eltayib, Mona Timan Idriss, Noura A. A. Alhudaib, Tilal Elsaman, Magdi Awadalla Mohamed

Journal of Chemistry · 03.06.2023 · 2023 · 1-13

DOI: 10.1155/2023/1481595 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Chemistry, erschienen am 03.06.2023. Verfasst von Malik Suliman Mohamed und 7 weiteren Autor:innen. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Al Jouf University.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Keeping in view the varying therapeutic attributes of 5-nitrofuran and isatin derivatives, novel 5-nitrofuran‒isatin molecular hybrids (2, 5–7) were synthesized by standard protocols, characterized by various spectroscopic techniques, and eventually evaluated against a group of pathogenic bacteria and fungi. Greater potency against Methicillin-resistant Staphylococcus aureus (MRSA) was exhibited by hybrids 5 and 6 with minimum inhibitory concentration values of 8 and 1 μg/mL, respectively. Cytotoxicity against both human embryonic kidney cells (HEK-293) and human red blood cells (RBCs) was investigated for the hybrids in hand. All hybrids appeared to have good safety; all of them were devoid of cytotoxicity, and none displayed hemolytic activity at the highest test concentration (CC50 and HI10 > 32 μg/mL). To support the postulation that these hybrids would be analogous to drugs containing the 5-nitrofurn ring system, molecular docking was carried out to streamline the binding affinity of the investigated hybrids towards the E. coli nitroreductase (NTR). Compared to the standard drug nitrofurazone, hybrid 6 demonstrated a higher affinity and better binding interactions with the NTR binding pocket. Therefore, it could be concluded that 6 displays its antibacterial action through a mechanism similar to that of nitrofurazone. Nonetheless, further wet investigations are to be conducted to confirm this finding. Encouraged by the well-established anticancer activity of isatin derivatives, 2, 5–7 were assessed for their potential antitumor activity, and they well demonstrated potent inhibitory activity against the human colon cancer cell line HCT 116 (IC50 = 1.62–8.8 μM) with isatin hybrid 3 being the best (IC50 = 1.62 μM). Thus, it is herein reported that these 5-nitrofuran‒isatin molecular hybrids could represent an ideal starting point for future studies to develop potent antimicrobial agents.

Förderung

  • Al Jouf University

Zitieren

APA

Mohamed, M. S., Elamin, K. M., Alenazy, R., Eltayib, E. M., Idriss, M. T., Alhudaib, N. A. A., Elsaman, T., & Mohamed, M. A. (2023). Synthesis, Antimicrobial, and Anticancer Activities of Novel Nitrofuran Derivatives. Journal of Chemistry, 2023, 1-13. https://doi.org/10.1155/2023/1481595

Vancouver

Mohamed MS, Elamin KM, Alenazy R, Eltayib EM, Idriss MT, Alhudaib NAA, et al. Synthesis, Antimicrobial, and Anticancer Activities of Novel Nitrofuran Derivatives. Journal of Chemistry. 2023;2023:1-13. doi:10.1155/2023/1481595

BibTeX
@article{Mohamed2023,
  author = {Mohamed, Malik Suliman and Elamin, Khaled M. and Alenazy, Rawaf and Eltayib, Eyman Mohamed and Idriss, Mona Timan and Alhudaib, Noura A. A. and Elsaman, Tilal and Mohamed, Magdi Awadalla},
  title = {Synthesis, Antimicrobial, and Anticancer Activities of Novel Nitrofuran Derivatives},
  journal = {Journal of Chemistry},
  year = {2023},
  volume = {2023},
  pages = {1--13},
  doi = {10.1155/2023/1481595}
}
Kostenlos starten →